Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
US6313156A · kind A · utility
4Cited by
3References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2000 |
| Grant date | Nov 6, 2001 |
| Priority date | — |
| Expiry date | Nov 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.